The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ICML 2023 | Comparing various prognostic scores used to predict outcomes in elderly patients with DLBCL
In this video, Fernando Martin-Moro, MD, Ramón y Cajal University Hospital, Madrid, Spain, discusses the results of a retrospective analysis which compared various prognostic scores used to predict outcomes in elderly patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP or R-mini-CHOP. Four prognostic scores were compared in this study: aaIPI, LAB-PI, NCCN-IPI and GELTAMO-IPI, and Dr Martin-Moro explains that while all of these scores are useful in predicting patient outcomes, the LAB-PI appears to be the best tool. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
